Legend Biotech Corporation (LEGN)
USD 30.16
(-5.8%)
USD 30.16
(-5.8%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -518.25 Million USD | -16.11% |
| 2022 | -446.34 Million USD | -15.57% |
| 2021 | -386.2 Million USD | -27.26% |
| 2020 | -303.47 Million USD | -128.23% |
| 2019 | -132.97 Million USD | -4676.29% |
| 2018 | -2.78 Million USD | -129.73% |
| 2017 | 9.36 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -59.79 Million USD | 58.71% |
| 2024 Q2 | -18.19 Million USD | 69.57% |
| 2023 Q4 | -144.81 Million USD | -132.8% |
| 2023 FY | -518.25 Million USD | -16.11% |
| 2023 Q3 | -62.2 Million USD | 68.76% |
| 2023 Q2 | -199.12 Million USD | -77.63% |
| 2023 Q1 | -112.1 Million USD | 17.5% |
| 2022 Q4 | -135.87 Million USD | -59.94% |
| 2022 Q3 | -84.95 Million USD | 56.03% |
| 2022 Q2 | -193.22 Million USD | -359.18% |
| 2022 Q1 | -42.08 Million USD | 52.36% |
| 2022 FY | -446.34 Million USD | -15.57% |
| 2021 FY | -386.2 Million USD | -27.26% |
| 2021 Q4 | -88.33 Million USD | 29.55% |
| 2021 Q3 | -125.39 Million USD | -36.91% |
| 2021 Q1 | -80.89 Million USD | -39.9% |
| 2021 Q2 | -91.58 Million USD | -13.21% |
| 2020 Q2 | -134.87 Million USD | -204.96% |
| 2020 FY | -303.47 Million USD | -128.23% |
| 2020 Q4 | -57.82 Million USD | 13.1% |
| 2020 Q3 | -66.54 Million USD | 50.66% |
| 2020 Q1 | -44.22 Million USD | 30.83% |
| 2019 Q4 | -63.94 Million USD | -130.04% |
| 2019 Q2 | -28.8 Million USD | -131.71% |
| 2019 Q1 | -12.43 Million USD | 0.0% |
| 2019 FY | -132.97 Million USD | -4676.29% |
| 2019 Q3 | -27.79 Million USD | 3.49% |
| 2018 FY | -2.78 Million USD | -129.73% |
| 2017 FY | 9.36 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -254.003% |
| Alkermes plc | 355.75 Million USD | 245.676% |
| Agenus Inc. | -245.76 Million USD | -110.877% |
| Aptorum Group Limited | -2.82 Million USD | -18247.567% |
| Ardelyx, Inc. | -66.06 Million USD | -684.437% |
| Dyadic International, Inc. | -6.79 Million USD | -7526.473% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -55269.017% |
| Lantern Pharma Inc. | -15.96 Million USD | -3146.893% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2623.512% |
| Novavax, Inc. | -545.06 Million USD | 4.918% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -789.05% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -602.336% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2694.41% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -5089.806% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -778.655% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -38.708% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2029.29% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1287.933% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -214.906% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -606.578% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2454.108% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -732.47% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1495.364% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -291.156% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -17.72% |
| AlloVir, Inc. | -190.41 Million USD | -172.166% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -152.468% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1721.503% |
| Bicycle Therapeutics plc | -180.66 Million USD | -186.861% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -189.442% |
| ChromaDex Corporation | -4.93 Million USD | -10395.221% |
| Chimerix, Inc. | -82.09 Million USD | -531.286% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1061.918% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -407.744% |
| CRISPR Therapeutics AG | -153.61 Million USD | -237.383% |
| Precision BioSciences, Inc. | -61.31 Million USD | -745.177% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -222.041% |
| Fortress Biotech, Inc. | -60.63 Million USD | -754.683% |
| Fortress Biotech, Inc. | -60.63 Million USD | -754.683% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -535.271% |
| ImmuCell Corporation | -5.77 Million USD | -8874.72% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -358.79% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3259.603% |
| Incyte Corporation | 597.59 Million USD | 186.723% |
| Innoviva, Inc. | 179.72 Million USD | 388.364% |
| IO Biotech, Inc. | -86.08 Million USD | -502.04% |
| Jaguar Health, Inc. | -41.3 Million USD | -1154.852% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -238.746% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1093.699% |
| ContextLogic Inc. | -317 Million USD | -63.487% |
| MiMedx Group, Inc. | 67.43 Million USD | 868.478% |
| MEI Pharma, Inc. | 17.77 Million USD | 3015.142% |
| NextCure, Inc. | -62.72 Million USD | -726.258% |
| Onconetix, Inc. | -37.4 Million USD | -1285.347% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1212.733% |
| Opthea Limited | -220.24 Million USD | -135.311% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -913.025% |
| Vaxcyte, Inc. | -402.26 Million USD | -28.834% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1106.864% |
| Precigen, Inc. | -95.9 Million USD | -440.388% |
| Pharming Group N.V. | -10.54 Million USD | -4813.292% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -157.081% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2011.616% |
| PureTech Health plc | -65.69 Million USD | -688.855% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1965.498% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -144.206% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2029.29% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -101.005% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1802.687% |
| Acelyrin, Inc. | -381.64 Million USD | -35.796% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4131820.665% |
| Summit Therapeutics Inc. | -614.92 Million USD | 15.721% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1419.762% |
| Senti Biosciences, Inc. | -92.91 Million USD | -457.748% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -394.994% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1033.936% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1374.826% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -3864.653% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -7652.491% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1665.05% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5996.389% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -801.108% |
| Seer, Inc. | -86.27 Million USD | -500.686% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -673.571% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -688.039% |
| ESSA Pharma Inc. | -26.58 Million USD | -1849.617% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1304.504% |
| GT Biopharma, Inc. | -7.59 Million USD | -6721.824% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -114.722% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -898.082% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 825.744% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -852.288% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -955.077% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -5109.763% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 9.529% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -14344.091% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -915.03% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -111.02% |
| Aptose Biosciences Inc. | -51.2 Million USD | -912.076% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -427.228% |
| Soligenix, Inc. | -6.14 Million USD | -8339.615% |
| Century Therapeutics, Inc. | -136.67 Million USD | -279.193% |
| Kura Oncology, Inc. | -152.63 Million USD | -239.547% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -480.885% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -4817.954% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 91750.132% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -90981.547% |
| Autolus Therapeutics plc | -208.38 Million USD | -148.703% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -620.818% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -632.049% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2291.794% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -130.079% |
| GRI Bio, Inc. | -13.03 Million USD | -3875.255% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -12434.629% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -317.664% |
| IGM Biosciences, Inc. | -246.41 Million USD | -110.317% |
| INmune Bio, Inc. | -30 Million USD | -1627.053% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -368.758% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1128.271% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3146.868% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3181.13% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -768.315% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -412.276% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -87.688% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -117.853% |
| Verastem, Inc. | -87.36 Million USD | -493.192% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -856.4% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -221.227% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -344.251% |
| Histogen Inc. | -10.62 Million USD | -4779.522% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3527.513% |
| Surrozen, Inc. | -43.04 Million USD | -1104.066% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3432.506% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10087.754% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -890.188% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1951.435% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1823.877% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -6101.372% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -243.021% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -959.26% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1643.495% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -4874.743% |
| Apollomics, Inc. | -172.6 Million USD | -200.261% |
| Amarin Corporation plc | -59.11 Million USD | -776.732% |
| Mesoblast Limited | -87.95 Million USD | -489.22% |
| Turnstone Biologics Corp. | -55.2 Million USD | -838.866% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -252.645% |
| Synaptogenix, Inc. | -6.03 Million USD | -8482.49% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3097.52% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -564.258% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10716.189% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -6068.078% |
| Exelixis, Inc. | 207.76 Million USD | 349.442% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1203.456% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -260.029% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 1.962% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4157.745% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -6548.808% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1585.434% |
| Gritstone bio, Inc. | -138.49 Million USD | -274.218% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -703.931% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -12856.512% |
| Avid Bioservices, Inc. | -140.75 Million USD | -268.201% |
| Insmed Incorporated | -749.56 Million USD | 30.86% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3311.921% |
| MediWound Ltd. | -6.71 Million USD | -7616.706% |
| OmniAb, Inc. | -50.61 Million USD | -923.833% |
| Alector, Inc. | -130.39 Million USD | -297.461% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -355.712% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -899.583% |
| Zai Lab Limited | -334.62 Million USD | -54.878% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -59.962% |
| Aura Biosciences, Inc. | -76.4 Million USD | -578.272% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -120.88% |
| Immunic, Inc. | -93.61 Million USD | -453.619% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -281.369% |
| Veracyte, Inc. | -74.4 Million USD | -596.541% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -6652.011% |
| FibroGen, Inc. | -284.23 Million USD | -82.335% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1875.656% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7301.63% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2651.885% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 224.931% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2197.734% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1151.844% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4189.757% |
| Galecto, Inc. | -38.34 Million USD | -1251.415% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2647.026% |
| Fortrea Holdings Inc. | -3.4 Million USD | -15142.765% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -309.221% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2876.59% |
| XBiotech Inc. | -24.55 Million USD | -2010.413% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -703.931% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -726.825% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -426.542% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2318.696% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -838.985% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 14.57% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -659.291% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -910171.542% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -128.77% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2227.399% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -135.881% |
| NexImmune, Inc. | -32.34 Million USD | -1502.299% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -9703.211% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3589.719% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 113.108% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2039.689% |
| Scopus BioPharma Inc. | -11.6 Million USD | -4363.925% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -343.718% |
| Ainos, Inc. | -13.77 Million USD | -3663.496% |
| Pluri Inc. | -20.88 Million USD | -2381.109% |
| Prothena Corporation plc | -147.02 Million USD | -252.487% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -355.124% |
| Celularity Inc. | -196.29 Million USD | -164.018% |
| Rallybio Corporation | -74.56 Million USD | -595.046% |
| Cue Biopharma, Inc. | -50.73 Million USD | -921.532% |
| MeiraGTx Holdings plc | -84.02 Million USD | -516.771% |
| Omeros Corporation | -117.81 Million USD | -339.895% |
| Humacyte, Inc. | -110.77 Million USD | -367.84% |
| Immunocore Holdings plc | -55.28 Million USD | -837.389% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2781.75% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2160.058% |
| Blueprint Medicines Corporation | -506.98 Million USD | -2.223% |
| CalciMedica, Inc. | -34.35 Million USD | -1408.438% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -665.798% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -266.503% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -212.599% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -82.964% |
| Pulmatrix, Inc. | -14.12 Million USD | -3570.094% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1372.522% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -527.138% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -7.702% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -394.182% |
| Cytokinetics, Incorporated | -526.24 Million USD | 1.518% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1337.0% |
| Nutriband Inc. | -5.48 Million USD | -9348.028% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1182.172% |
| Vor Biopharma Inc. | -117.86 Million USD | -339.709% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 111.917% |
| Evogene Ltd. | -23.87 Million USD | -2070.334% |
| ProKidney Corp. | -35.46 Million USD | -1361.188% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -332.733% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -6505.841% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 19.426% |
| CorMedix Inc. | -46.33 Million USD | -1018.392% |
| BioLineRx Ltd. | -60.61 Million USD | -755.007% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -409.371% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1162.003% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1188.42% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -542.595% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -586.238% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -77.368% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1759.14% |
| MediciNova, Inc. | -8.57 Million USD | -5946.235% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -320.398% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6086.753% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1895.836% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -116.627% |
| Biomea Fusion, Inc. | -117.25 Million USD | -341.989% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 17.292% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1658.82% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -238.37% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -147.542% |
| Absci Corporation | -110.56 Million USD | -368.728% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1618.919% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -413.952% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -119.658% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3779.736% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -168.578% |
| Allakos Inc. | -185.7 Million USD | -179.08% |
| Imunon, Inc. | -19.51 Million USD | -2555.673% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -432.444% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 588.274% |
| BioAtla, Inc. | -123.46 Million USD | -319.768% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4157.745% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3123.374% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -58.359% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1302.62% |
| XOMA Corporation | -40.83 Million USD | -1169.266% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -408.741% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -337.297% |
| aTyr Pharma, Inc. | -50.38 Million USD | -928.506% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -491.081% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -241.498% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -117.997% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1375.708% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -6304.57% |
| Akari Therapeutics, Plc | -10 Million USD | -5078.397% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -769679.428% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 284.043% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7675.872% |
| UroGen Pharma Ltd. | -102.24 Million USD | -406.88% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -385.288% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -6563.774% |
| Orgenesis Inc. | -55.36 Million USD | -836.136% |
| Entera Bio Ltd. | -8.88 Million USD | -5730.285% |
| GH Research PLC | -35.58 Million USD | -1356.301% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2386.823% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -569.683% |
| Xencor, Inc. | -126.08 Million USD | -311.029% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -13662.48% |
| Replimune Group, Inc. | -215.79 Million USD | -140.161% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2336.946% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 20755.799% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7675.872% |
| Portage Biotech Inc. | -75.33 Million USD | -587.896% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6086.753% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -436.19% |
| OncoCyte Corporation | -27.78 Million USD | -1765.498% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3762.606% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -4559.921% |
| Purple Biotech Ltd. | -19.88 Million USD | -2506.911% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -7283.587% |
| scPharmaceuticals Inc. | -54.81 Million USD | -845.546% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2860.412% |
| HilleVax, Inc. | -123.56 Million USD | -319.415% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5027.674% |
| Tharimmune, Inc. | -9.31 Million USD | -5461.206% |
| Genprex, Inc. | -30.86 Million USD | -1579.346% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -119.669% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1622.117% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -28982.716% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -9685.735% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3080077.303% |
| Savara Inc. | -54.69 Million USD | -847.483% |
| Curis, Inc. | -47.41 Million USD | -993.063% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1618.27% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3255.462% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -9206.051% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1638.232% |
| BeiGene, Ltd. | -881.7 Million USD | 41.222% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2333.803% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -18.766% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -556.392% |
| Erasca, Inc. | -125.04 Million USD | -314.464% |
| bluebird bio, Inc. | -211.91 Million USD | -144.56% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10264.05% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 409.138% |
| DBV Technologies S.A. | -72.72 Million USD | -612.612% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10264.05% |
| Moderna, Inc. | -4.71 Billion USD | 89.006% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1190.57% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -9001.756% |
| Molecular Templates, Inc. | -8.12 Million USD | -6279.296% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -758.207% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -365.223% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -282.893% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -981.521% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -266.441% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -169.349% |
| MacroGenics, Inc. | -9.05 Million USD | -5621.506% |
| RenovoRx, Inc. | -10.23 Million USD | -4965.031% |
| Adicet Bio, Inc. | -142.65 Million USD | -263.284% |
| Prime Medicine, Inc. | -198.13 Million USD | -161.569% |
| Aditxt, Inc. | -32.38 Million USD | -1500.496% |
| Adagene Inc. | -18.94 Million USD | -2635.374% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6987.987% |
| Quantum-Si incorporated | -95.96 Million USD | -440.073% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -335.401% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3455.098% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 491.638% |
| SciSparc Ltd. | -5.12 Million USD | -10018.196% |
| Vericel Corporation | -3.18 Million USD | -16187.052% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -430866.122% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1627.205% |
| Generation Bio Co. | -126.61 Million USD | -309.325% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -610.999% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -528.629% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -97.701% |
| Invivyd, Inc. | -198.64 Million USD | -160.897% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -51.548% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -5866.15% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2372.446% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -5148.673% |
| 2seventy bio, Inc. | -217.57 Million USD | -138.201% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1735.242% |
| Clene Inc. | -49.5 Million USD | -946.893% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2225.308% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -948.376% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1895.836% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -57.972% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1492.525% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2381.048% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -424.592% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -593.279% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -222.287% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 15.739% |
| Evaxion Biotech A/S | -22.12 Million USD | -2242.391% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -541.912% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -159.039% |
| Trevena, Inc. | -40.28 Million USD | -1186.341% |
| Surrozen, Inc. | -43.04 Million USD | -1104.066% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -649.637% |
| Cingulate Inc. | -23.53 Million USD | -2102.061% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -7397.888% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1200.186% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -6621.255% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -474.497% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -745.632% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -770.971% |
| Clearmind Medicine Inc. | -11.95 Million USD | -4235.028% |
| Kronos Bio, Inc. | -112.67 Million USD | -359.963% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -648.954% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -20433930.037% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -503.358% |
| Statera Biopharma, Inc. | -174.4 Million USD | -197.15% |
| ImmunityBio, Inc. | -583.19 Million USD | 11.136% |
| Korro Bio, Inc. | -81.17 Million USD | -538.464% |
| Kineta, Inc. | -14.09 Million USD | -3575.821% |
| BioVie Inc. | -32.12 Million USD | -1513.466% |
| Codexis, Inc. | -76.24 Million USD | -579.767% |
| Celularity Inc. | -196.29 Million USD | -164.018% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -141.578% |
| Celcuity Inc. | -63.77 Million USD | -712.576% |
| Virax Biolabs Group Limited | -6.73 Million USD | -7596.609% |
| Cibus, Inc. | -267.62 Million USD | -93.648% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1185.161% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1347.192% |
| IN8bio, Inc. | -30 Million USD | -1627.11% |
| Kodiak Sciences Inc. | -260.49 Million USD | -98.953% |
| Annexon, Inc. | -134.23 Million USD | -286.074% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -342.328% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -746.433% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1542.956% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -41.489% |
| Eyenovia, Inc. | -27.26 Million USD | -1801.075% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2500.324% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -96769.907% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -578.307% |
| Arcellx, Inc. | -70.69 Million USD | -633.136% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1150.583% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -287.289% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1625.385% |
| Moolec Science SA | -51.78 Million USD | -900.705% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -889.582% |
| Geron Corporation | -184.12 Million USD | -181.466% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1134.702% |
| Royalty Pharma plc | 1.13 Billion USD | 145.668% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -281.192% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -5728.447% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2339.619% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -201.89% |
| Humacyte, Inc. | -110.77 Million USD | -367.84% |
| Structure Therapeutics Inc. | -89.62 Million USD | -478.279% |
| 89bio, Inc. | -142.18 Million USD | -264.482% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -651.528% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -4894.257% |
| Genelux Corporation | -28.29 Million USD | -1731.48% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1683.086% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -192.602% |
| Notable Labs, Ltd. | -11.26 Million USD | -4500.977% |
| Liquidia Corporation | -78.5 Million USD | -560.179% |
| Mustang Bio, Inc. | -51.6 Million USD | -904.329% |
| Immunovant, Inc. | -259.33 Million USD | -99.839% |
| Quantum-Si incorporated | -95.96 Million USD | -440.073% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -611.409% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2574.031% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -439.904% |
| Acasti Pharma Inc. | -12.85 Million USD | -3932.164% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2207.673% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3146.868% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -184.141% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -11948.168% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4056.006% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1657.329% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1229.265% |
| PepGen Inc. | -78.62 Million USD | -559.138% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1640.918% |
| United Therapeutics Corporation | 984.8 Million USD | 152.625% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2228.185% |
| Solid Biosciences Inc. | -96.01 Million USD | -439.764% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10716.189% |
| Immuneering Corporation | -53.47 Million USD | -869.213% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10087.754% |
| Silo Pharma, Inc. | -3.7 Million USD | -13904.28% |
| Belite Bio, Inc | -31.63 Million USD | -1538.385% |
| XOMA Corporation | -40.83 Million USD | -1169.266% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -853.286% |
| Bionomics Limited | -15.49 Billion USD | 96.655% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -517.079% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1677.46% |
| uniQure N.V. | -308.47 Million USD | -68.004% |
| Cassava Sciences, Inc. | -97.21 Million USD | -433.09% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6987.987% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -319.877% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1546.505% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -6218.858% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1682.902% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -96769.907% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1875.656% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3043.791% |
| Altimmune, Inc. | -88.44 Million USD | -485.949% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -241.892% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1677.46% |
| Compugen Ltd. | -18.75 Million USD | -2663.432% |
| Peak Bio, Inc. | -1259.26 USD | -41155340.497% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1025.44% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2282.667% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -52.972% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -524.749% |
| Zura Bio Limited | -60.36 Million USD | -758.605% |
| PolyPid Ltd. | -23.86 Million USD | -2071.607% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3194.266% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -524.749% |
| Instil Bio, Inc. | -156.08 Million USD | -232.029% |
| argenx SE | -295.05 Million USD | -75.648% |
| Immunome, Inc. | -106.8 Million USD | -385.229% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1119.593% |
| Verona Pharma plc | -54.36 Million USD | -853.216% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -418.685% |
| Shattuck Labs, Inc. | -87.29 Million USD | -493.661% |
| CervoMed Inc. | -2.17 Million USD | -23762.077% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -315.764% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3791.965% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1089.884% |
| Moolec Science SA | -51.78 Million USD | -900.705% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2997020.589% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -283.558% |
| AnaptysBio, Inc. | -163.61 Million USD | -216.744% |
| Design Therapeutics, Inc. | -66.86 Million USD | -675.11% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -536.566% |
| NeurAxis, Inc. | -14.62 Million USD | -3443.209% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1268.075% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1422.754% |
| Achilles Therapeutics plc | -69.66 Million USD | -643.923% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -418.685% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2499.704% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 17324.665% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -20433930.037% |
| Nutriband Inc. | -5.48 Million USD | -9348.028% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -414.667% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -966.213% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -572.263% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1425.623% |
| MoonLake Immunotherapeutics | -36 Million USD | -1339.304% |
| Palisade Bio, Inc. | -12.3 Million USD | -4113.447% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1130.306% |
| Beam Therapeutics Inc. | -132.52 Million USD | -291.055% |
| Neurogene Inc. | -36.31 Million USD | -1327.029% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -217.14% |
| AEON Biopharma, Inc. | -52.55 Million USD | -886.099% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -428.039% |
| Sesen Bio, Inc. | -19.88 Million USD | -2506.387% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -623.98% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4041.428% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -16.714% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -364.527% |
| Athira Pharma, Inc. | -117.67 Million USD | -340.423% |
| Vaccinex, Inc. | -20.25 Million USD | -2459.153% |
| HCW Biologics Inc. | -24.99 Million USD | -1973.491% |
| XOMA Corporation | -40.83 Million USD | -1169.266% |
| Nektar Therapeutics | -276.05 Million USD | -87.735% |
| Arvinas, Inc. | -367.3 Million USD | -41.098% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -769679.428% |
| Merus N.V. | -154.93 Million USD | -234.489% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -431.935% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1551.279% |
| Rezolute, Inc. | -68.45 Million USD | -657.028% |
| Clene Inc. | -49.5 Million USD | -946.893% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3260.165% |
| BeyondSpring Inc. | -21.02 Million USD | -2364.825% |
| Synlogic, Inc. | -57.28 Million USD | -804.741% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -4254.71% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4687.124% |
| Peak Bio, Inc. | -1259.26 USD | -41155340.497% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1286.893% |
| Krystal Biotech, Inc. | 10.93 Million USD | 4840.706% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -262.165% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -59.412% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -11120.133% |
| MannKind Corporation | -11.93 Million USD | -4241.213% |
| Ikena Oncology, Inc. | -68.16 Million USD | -660.282% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2366.115% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -457.664% |
| Gossamer Bio, Inc. | -179.81 Million USD | -188.212% |
| CohBar, Inc. | -11.96 Million USD | -4232.46% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1909.671% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1618.919% |
| Mural Oncology plc | -207.44 Million USD | -149.825% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -317.56% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2733.58% |
| Disc Medicine, Inc. | -76.42 Million USD | -578.086% |
| Champions Oncology, Inc. | -7.27 Million USD | -7022.787% |
| REGENXBIO Inc. | -263.49 Million USD | -96.685% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -4783.166% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -990.946% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1264.419% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -417.411% |
| Vaxart, Inc. | -82.46 Million USD | -528.453% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 155376.049% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1280.446% |
| Cellectis S.A. | -101.05 Million USD | -412.823% |
| Longeveron Inc. | -21.41 Million USD | -2320.277% |
| Repare Therapeutics Inc. | -93.79 Million USD | -452.533% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 3.307% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -628.202% |
| Revolution Medicines, Inc. | -436.36 Million USD | -18.766% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -7786.988% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1581.333% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -647.485% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -700.615% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -5182.377% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 114.318% |
| Denali Therapeutics Inc. | -145.22 Million USD | -256.865% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -430866.122% |
| Veru Inc. | -93.15 Million USD | -456.349% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1817.4% |
| Cingulate Inc. | -23.53 Million USD | -2102.061% |
| Passage Bio, Inc. | -102.06 Million USD | -407.784% |
| Context Therapeutics Inc. | -23.96 Million USD | -2062.617% |
| Exicure, Inc. | -16.91 Million USD | -2964.053% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -174.329% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1272.349% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -7864.164% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -180.626% |
| Nuvalent, Inc. | -126.21 Million USD | -310.599% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -4828.404% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -496.524% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1596.746% |
| OmniAb, Inc. | -50.61 Million USD | -923.833% |
| Anew Medical, Inc. | 1.34 Million USD | 38599.694% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3130.003% |
| Lipocine Inc. | -16.35 Million USD | -3069.346% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -680.574% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -713.905% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1128.271% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -980.439% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2513.353% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 4.291% |
| Ocugen, Inc. | -63.07 Million USD | -721.608% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -441.359% |
| Q32 Bio Inc. | -112.96 Million USD | -358.79% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2914.507% |
| Alumis Inc. Common Stock | -154.99 Million USD | -234.373% |
| Equillium, Inc. | -13.33 Million USD | -3786.419% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -758.52% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -6388.04% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2649.179% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -777.177% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -352.517% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2719.977% |
| Dominari Holdings Inc. | -22.88 Million USD | -2164.898% |
| Edesa Biotech, Inc. | -8.37 Million USD | -6088.54% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2459.279% |
| Bio-Techne Corporation | 168.1 Million USD | 408.292% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -47.194% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 502.206% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -325.384% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1266.019% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -360.089% |
| Nkarta, Inc. | -117.5 Million USD | -341.063% |
| BioCardia, Inc. | -11.57 Million USD | -4378.904% |
| Iterum Therapeutics plc | -38.37 Million USD | -1250.64% |